rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
1999-4-15
|
pubmed:abstractText |
The behavioral phenotype of Prader-Willi syndrome (PWS) suggests hypothalamic dysfunction and altered neurotransmitter regulation. The purpose of this study was to examine whether there was any difference in the concentrations of monoamine metabolites in the cerebrospinal fluid (CSF) in PWS and non-PWS comparison cases.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-3223
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1321-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9861475-Adolescent,
pubmed-meshheading:9861475-Adult,
pubmed-meshheading:9861475-Age Factors,
pubmed-meshheading:9861475-Autistic Disorder,
pubmed-meshheading:9861475-Birth Weight,
pubmed-meshheading:9861475-Body Mass Index,
pubmed-meshheading:9861475-Child,
pubmed-meshheading:9861475-Child, Preschool,
pubmed-meshheading:9861475-Female,
pubmed-meshheading:9861475-Homovanillic Acid,
pubmed-meshheading:9861475-Humans,
pubmed-meshheading:9861475-Hydroxyindoleacetic Acid,
pubmed-meshheading:9861475-Infant,
pubmed-meshheading:9861475-Intelligence Tests,
pubmed-meshheading:9861475-Male,
pubmed-meshheading:9861475-Methoxyhydroxyphenylglycol,
pubmed-meshheading:9861475-Neurotransmitter Agents,
pubmed-meshheading:9861475-Obesity,
pubmed-meshheading:9861475-Phenotype,
pubmed-meshheading:9861475-Prader-Willi Syndrome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Cerebrospinal fluid monoamines in Prader-Willi syndrome.
|
pubmed:affiliation |
Department of Child and Adolescent Psychiatry, University of Göteborg, Mölndal.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|